Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Mach7 Technologies.
RELATED STOCKHEAD STORIES
Health & Biotech
Middle East healthcare expansion opens doors for ASX stocks
Health & Biotech
Health Check: Fisher & Paykel Healthcare shares tumble after Trump tariff king-hit
Health & Biotech
Scott Power: Mach7 launches $5M buyback, reconfirms guidance
Health & Biotech
ASX Quarterly Health Wrap: Blinklab starts key FDA study, Mach 7 set to meet FY25 guidance
Health & Biotech
Five ASX healthcare companies poised for game-changing catalysts
Health & Biotech
ASX imaging stocks target lucrative US veterans health market
Health & Biotech
Scott Power: Which company dropped 30pc on its latest quarterly result?
Health & Biotech
ASX health stocks developing tech to bridge labour gaps
Health & Biotech
Health Check: PharmX has 99pc share of pharmacy market but reckons it has prescription for growth
Health & Biotech
Scott Power: ASX health stocks rise as focus shifts to reporting season
Health & Biotech
ScoPo’s Powerplays: ASX health stocks fall in ‘lacklustre’ week
Health & Biotech
ScoPo’s Powerplays: ASX health stocks flat in ‘ocean with no breeze’
News
Market Highlights: Dow Jones breaks another record as focus turns to Nvidia’s big night
Health & Biotech
ScoPo’s Powerplays: ASX health stocks rise but are ‘lacking any momentum’
Experts
ScoPo’s Powerplays: ASX health stocks rise despite Friday selloff, and what’s this – a potential cure for ageing?
Health & Biotech
ScoPo’s Powerplays: ASX health stocks rise as M&A activity heats up
Health & Biotech
